Comorbidities in Developmental Disorders
Will be published approx. on 8. October 2010
Book
Paperback/Softback
176 pages
978-1-907655-00-5 (ISBN)
Description
In the last decade the term 'comorbidity' has gained popularity in the field of paediatric neurodisability, with the increasing recognition that many conditions are rarely present in isolation. Within this field, the term is often used to refer to the co-occurrence of conditions more frequently than would be expected by chance, which can include instances where one condition causes the other, where they share a common cause (for example, genetic), or where they are in fact manifestations of a single condition. Whether it is valid to use the term 'comorbidity' in all these situations, and how precisely it should be used, is something that the contributors to this book grapple with in their own fields of interest.
The contributors, all world experts in their fields, also discuss what we can learn from the presence of comorbidities, however defined, about the aetiology and treatment of neurodevelopmental disabilities. In particular, they demonstrate how our increasing understanding of the mechanisms underlying the common association of many 'comorbidities' is helping us to understand the natural history of these conditions and improve our management of them.
Readership
Paediatricians, paediatric neurologists, child psychiatrists, neurodevelopmentalists, and physical, occupational and speech therapists working with children with developmental disabilities.
Reviews / Votes
"In particular, they demonstrate how our increasing understanding of the mechanisms underlying the common association of many comorbidities is helping us to understand the natural history of these conditions and improve our management of them." (News Blaze, 15 March 2011) "The book Comorbidities in Developmental Disorders is a substantial and timely contribution to the discussion of the widely recognized, but underexplored area of coexisting conditions in childhood neurodisability." (International Journal of Disability, Development and Education, 2011)"This book is very useful for physicians who care for children with developmental disorders. It offers a clear explanation of the disorders as well as an understanding of the many associated co-morbidities." (Doody's, 2011)
"The book certainly has its practical value to the child neurologist in discussion of comorbidity in disorders more commonly seen. Its greater value may be provoking thought about the subtle but important complexities in the disorder less commonly appreciated." (Journal of Child Neurology, 2011)
"When you face a child who manifests seemingly multiple disabilities, which is the rule rather than the exception, this book will be an invaluable tool for your knowledge, reflection, and action." (International Journal of Disability, Community and Rehabilitation, 2011)
"The book should be useful to learners in all stages of training, but particularly for those pursuing a career in developmental disabilities." (Developmental Medicine and Child Neurology, 2011)
More details
Product info
Paperback
Series
Edition
1. Auflage
Language
English
Place of publication
Cambridge
United Kingdom
Target group
Professional and scholarly
Product notice
Paperback (trade)
Unsewn / adhesive bound
Dimensions
Height: 236 mm
Width: 168 mm
Thickness: 13 mm
Weight
431 gr
ISBN-13
978-1-907655-00-5 (9781907655005)
Schweitzer Classification
Other editions
Additional editions
Martin Bax | Christopher Gillberg
Comorbidities in Developmental Disorders
E-Book
10/2011
1st Edition
Mac Keith Press
€99.89
Available for download
Martin Bax | Christopher Gillberg
Comorbidities in Developmental Disorders
E-Book
10/2011
Mac Keith Press
€85.99
Available for download
Persons
Martin Bax was one of the pioneers of community paediatrics and brought a scholarly approach to the subject. He has inspired many paediatricians and has developed an active and productive research group. Dr Bax was for many years senior editor of Developmental Medicine and Child Neurology and was chairperson of the European Academy of Childhood Disability and President of the Society for the Study of Behavioural Phenotypes (SSBP).
Christopher Gillberg is Professor of Child and Adolescent Psychiatry at the University of Gothenburg, and Chief Physician at the Child Neuropsychiatry Clinic at Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg. He is also Professor of Child and Adolescent Psychiatry at University College London (Institute of Child Health), University of Glasgow and at the University of Strathclyde, Glasgow. He is the founding editor of European Child and Adolescent Psychiatry and is or has been on the editorial boards of several journals. He has written or co-authored more than 450 peer-reviewed papers.
Content
FOREWORD Christopher Verity (Cambridge, UK)
INTRODUCTION Martin Bax (London, UK) and Christopher Gillberg (Gothenburg, Sweden)
1. INTELLECTUAL DISABILITIES AND THEIR COMBORBIDITIES Jeremy Turk (London, UK)
2. HETEROGENEITY IN CEREBRAL PALSY: VARIATIONS IN NEUROLOGY, COMORBIDITY AND ASSOCIATED CONDITIONS J. Keith Brown (Edinburgh, UK), Paul Eunson (Edinburgh, UK) and Martin Bax (London, UK)
3. GILLES DE LA TOURETTE SYNDROME AND ITS COMMON COMORBIDITIES Michael Orth (Ulm, Germany) and Mary May Robertson (London, UK)
4. COMORBIDITY IN NEURODEVELOPMENTAL DISORDERS: THE CASE OF ATTENTION-DEFICIT-HYPERACTIVITY DISORDER Eric Taylor (London, UK)
5. EARLY LANGUAGE DISORDER AS A FREQUENT COMORBIDITY IN MANY DEVELOPMENTAL DISORDERS IN YOUNG CHILDREN Isabelle Rapin (Bronx, NY, USA)
6. AUTISM AND EPILEPSY: COMORBIDITY, COEXISTENCE OR COINCIDENCE? Christopher Gillberg (Gothenburg, Sweden) and Brian Neville (London, UK)
7. GENETIC CORRELATES OF PSYCHIATRIC COMORBIDITY: FRAGILE X SYNDROME Sufen Chiu, David Hessl, Josh Day and Randi Hagerman (Sacramento, CA, USA)
8. CHANNELOPATHIES Sameer Zuberi (Glasgow, UK)
9. INCREASED LONGEVITY AND THE COMORBIDITIES ASSOCIATED WITH INTELLECTUAL AND DEVELOPMENTAL DISABILITY Emma J. Glasson and Alan H. Bittles (Perth, Australia)
10. COMORBIDITY: CLASSIFICATION ARTEFACT AND CLINICAL REALITY Rutger Jan van der Gaag (Nijmegen, The Netherlands)